| abstract |
Compounds of formula (I, II, III) wherein the substituents havenand their pharmaceutically acceptable salts;nhow they are prepared. The compounds are inhibitorsninfluenza virus neuraminidases, and may be used inntreatment of influenza virus infected patients. |